Characterization of a novel amphiregulin-related molecule in 12-O-tetradecanoylphorbol-13-acetate-treated breast cancer cells

Journal of Cellular Physiology

Volumn 169, Issue 3, 1996, Pages 497-508

  Martinez Lacaci, Isabel ^a,c   Johnson, Gibbes R ^b   Salomon, David S ^c   Dickson, Robert B ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; AMPHIREGULIN; BRYOSTATIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; GLYCOSIDASE; MESSENGER RNA; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TUNICAMYCIN;

ARTICLE; BREAST CANCER; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR CELL;

BREAST NEOPLASMS; CELL COMPARTMENTATION; ESTRADIOL; FEMALE; GLYCOPROTEINS; GLYCOSYLATION; GROWTH SUBSTANCES; HEPARIN; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR WEIGHT; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030481067     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199612)169:3<497::AID-JCP10>3.0.CO;2-3     Document Type: Article

References (47)

1. Berthois, Y., Katzenellenbogen J.A., and Katzenellenbogen, B.S. (1986) Phenol red in tissue culture is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. U.S.A., 83:2496-2500.
2. Besner, G.E., Whelton, D., Crissman-Combs, M.A., Steffen, C.L., Kim, G.Y., and Brigstock, D.R. (1992) Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin-binding HB-EGF fragments. Growth Factors, 7:289-296.
3. Bringman, T.S., Lindquist, P.B., and Derynck, R. (1987) Different transforming growth factor-species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell, 48:429-440.
4. Burgess, T.L., Ross, S.L., Qian, Y., Brankow, and Hu, S. (1995) Biosynthethic processing of neu differentiation factor. J. Biol. Chem., 270:19188-19186.
5. Burwen, S.J., and Jones, A.L. (1987) The association of polypeptide hormones and growth factors with the nuclei of target cells. Trends Biochem. Sci., 12:159-162.
6. Cao, H., Lei, Z.M., Bian, L., and Rao, Ch.V. (1995) Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. Endocrinol., 136:3163-3172.
7. Cook, P.W., Mattox, P.A., Keeble, W.W., Pittelkow, M.R., Plowman, G.D., Shoyab, M., Adelman, J.P., and Shipley, G.D. (1991) A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol. Cell Biol., 11:2547-2557.
8. 76 converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppresible growth factor. J. Cell. Physiol., 163:407-417.
9. Cook, P.W., Ashton, N.M., Karkaria, C.E., Siess, D.C., and Shipley, G.D. (1995b) Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J. Cell. Physiol., 163:418-429.
10. Dickson, R.B., Bano, M., Johnson, M.D., Shi, Y.E., Martinez-Lacaci, I., Amundadottir, L.T., Ziff, B., and Kurebayashi, J. (1994) Steroid regulation of growth factors and protooncogenes in the normal and malignant mammary gland. In: Protooncogenes and Growth Factors in Steroid Hormone Induced Growth and Differentiation. S.A. Khan and G.M. Stancel, eds. CRC Press, Boca Ratón, FL. pp. 143-174.
11. Dickson, R.B., and Lippman, M.E. (1995) The molecular basis of breast cancer. In: The Molecular Basis of Cancer. J. Mendelsohn, P. Howley, L. Liotta, and M. Israel, eds. W.B. Saunders Co, Philadelphia, PA, pp. 358-386.
12. Ebert, M., Yokoyama, M., Kobrin, M.S., Fries, H., Lopez, M.E., Büchler, M.K., Johnson, G.R., and Korc, M. (1994) Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res., 54:3959-3962.
13. Fiedler, K., and Simons., K. (1995) The role of N-glycans in the secretory pathway. Cell, 81:309-312.
14. Gill, G.N., Kawamoto, T., Cochet, C., Le, A., Sato, J.D., Masui, H., McLeod, C., and Mendelsohn, J. (1984) Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem., 259:7755-7760.
15. Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E., and Taniguchi N. (1995) Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: Conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell, 6:967-980.
16. Holt, S.J., Alexander, P., Inman, C.B., and Davies, D.E. (1994) Epidermal growth factor induced tyrosine phosphorylation of nuclear proteins associated with translocation of epidermal growth factor receptor into the nucleus. Biochem. Pharmacol., 47:117-126.
17. Holt, S.J., Alexander, P., Inman, C.B., and Davies, D.E. (1995) Ligand-induced translocation of epidermal growth factor receptor to the nucelus of NR6/HER fibroblasts is serum dependent. Exp. Cell Res., 217:554-558.
18. Ishikawa, M., Dennis, J.W., Man, S., and Kerbel, R.S. (1988) Isolation and characterisation of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice. Cancer Res., 48:665-670.
19. Johnson G.R., Saeki, T., Auersperg, N., Gordon, A.W., Shoyab, M., Salomon, D.S., and Stromberg, K. (1991) Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: Nuclear localization of endogenous amphiregulin. Biochem. Biophys. Res. Commun., 180:481-488.
20. Johnson, G.R., Saeki, T., Gordon, A.W., Shoyab, M., Salomon, D.S, and Stromberg, K. (1992) Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon J. Cell Biol., 118:741-751.
21. Johnson, G.R., Prigent, S.A., Gullik, W.J., and Stromberg K. (1993) Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. J. Biol. Chem., 268:18835-18843.
22. Johnson, G.R., and Wong, L. (1994) Heparin sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor. J. Biol. Chem., 269:27149-27154.
23. Kan, M., Wang, F., Xu, J., Crabb, J.W., Hou, J., and McKeehan, W.L. (1993) An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science, 259:1918-1921.
24. Kawamoto, S., and Hidaka, H. (1984) 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem. Biophys. Res. Comm., 125:258-264.
25. Kimura, H. (1993) Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc. Natl. Acad. Sci. U.S.A., 90:2165-2169.
26. Levine, J.E., and Prytowsky, M.B. (1995) Polypeptide growth factors in the nucleus: A review of function and translocation. Neuroimmodul., 2:290-298.
27. Li, S., Plowman, G.D., Buckley, S.D., and Shipley, G.D. (1992) Heparin inhibition of autonomouss growth implicates amphiegulin as an autocrine growth factor for normal human mammary epithelial cells. J. Cell Physiol., 153:103-111.
28. Lobel, P., Dahms, N.M., and Kornfled, S. (1988) Cloning and sequence analysis of the cation-independent mannose 6-phophate receptor. J. Biol. Chem., 263:2563-2570.
29. Martínez-Lacaci, I., Saceda, M., Plowman, G.D., Johnson G.R., Normanno, N., Salomon, D.S., and Dickson, R.B. (1995) Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cells. Endocrinology, 136:3983-3991.
30. Martínez-Lacaci, I., and Dickson, R.B. (1996) Dual regulation of members of the epidermal growth factor family pathways in breast cancer by sex steroids and protein kinase C. J. Steroid. Biochem. Mol. Biol., 57:1-11.
31. Modrell, B., McDonald, V.L., and Shoyab, M. (1992) The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding proteins. Growth Factors, 7:305-314.
32. Morgan, D.O., Edman, J.C., Standring, D.N., Fried, V.A., Smith, M.C., Roth, R.A., and Rutter, W.J. (1987) Insulin-like growth factor II receptor as a multifunctional binding protein. Nature, 329:301-307.
33. Normanno, N., Qi, C.-F., Gullick, W.J., Persico, G., Yarden Y., Wen, D., Plowman, G.D., Kenney, N., Johnson, G.R., Kim, N., Brandt, R., Martínez-Lacaci, I., Dickson, R.B., and Salomon, D.S. (1993) Expression of amphiregulin, cripto-1, and heregulin in human breast cancer cells. Intl. J. Oncol., 2:903-911.
34. Normanno, N., Selvam, M.P., Qi, C.-F., Saeki, T., Johnson G., Kim, N., Ciardiello F., Shoyab, M., Plowman, G., Brandt, R., Todaro, G., and Salomon, D.S. (1994) Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erB-2-transformed human mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A., 91:2790-2794.
35. Pandiella A., and Massagué, J. (1991) Cleavage of the membrane precursor for transforming growth factor a is a regulated process. Proc. Natl. Acad. Sci. U.S.A., 88:1726-1730.
36. Pettit G.R., Herald, C.L., Doubek, D.L., Herald, D.L., Arnold, E., and Clardy, J. (1982) Isolation and structure of bryostatin 1. J. Am. Chem. Soc., 104:6846-6848.
37. Piepkorn, M., Lo, C., and Plowman, G.D. (1994) Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J. Cell Physiol., 159:114-120.
38. Plowman, G.D., Green, J.M., McDonald, V.L., Neubauer, M.G., Disteche, C.M., Todaro, G.J., and Shoyab M. (1990) The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor inhibitor activity. Mol. Cell Biol., 10:1969-1981.
39. Qi, C.-F., Liscia, D.S., Normanno, N., Merlo, G., Johnson, G.R., Gullick, W.J., Ciardiello, F., Saeki, T., Brandt, R., Kim, N., and Salomon, D.S. (1994) Expression of transforming growth factor, amphiregulin and cripto-1 in human breast carcinomas. Br. J. Cancer, 69:16896-16901.
40. Raab, G., Higashiyama, S., Hetelekidis S., Abraham, J.A., Damm, D., Ono, M., and Klagsbrun M. (1994) Biosynthesis and processing by phorbol ester of the cell surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem. Biophys. Res. Comm., 204:592-597.
41. Rademacher, T.W., Parekh, R.B., and Dwek, R.A. (1988) Glycobiology. Annu. Rev. Biochem., 57:785-838.
42. Ramesh and Levine (1995) Pro-transforming growth factor-alpha processing in human colon carcinoma cells: Role of protein kinase C. Int. J. Cancer, 62:492-497.
43. Saeki, T., Stromberg, K., Qi, C.-F., Gullick, W.J., Tahara, E., Normanno, N., Ciardiello, F., Kenney, N., Johnson, G.R., and Salomon, D.S. (1992) Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res., 52:3467-3473.
44. Shoyab, M., McDonald, V.L., Bradley, J.G., and Todaro, G.J. (1988) Amphiregulin: A bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc. Natl. Acad. Sci. U.S.A., 85:6528-6532.
45. Shoyab, M., Plowman, G.D., McDonald, V.L., Bradley, J.G., and Todaro, G.J. (1989) Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science, 243:1074-1076.
46. Thorne, B.A., and Plowman, G.D. (1994) The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion. Mol. Cell Biol., 14:1635-1646.
47. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., and Ornitz, D.M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor and its high affinity receptor. Cell, 64:841-848.